Abstract:Objective To analyze the differential gene expression profile of serum exosomes in patients with acute cerebral infarction (ACI) and clarify the changes in gene expression related to cerebral infarction injury and the potential serum markers. Methods Four patients with ACI and five healthy people were enrolled in the Phase Ⅰ study. After serum isolation from peripheral blood, exosomes were extracted with exosomes kits, high-throughput detection of mRNA was performed with gene chips, and differentially expressed mRNAs were screened. Gene Ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed simultaneously. Furthermore, real-time polymerase chain reaction (qRT-PCR) was used to verify the expression levels of the screened differential mRNAs in the serum exosomes collected in Phase Ⅱ from 32 patients each in the ACI case and normal control groups. Results In the Phase Ⅰ study, there were 248 differentially expressed mRNAs (fold change ≥ 2.0, P < 0.05) among five patients in the normal control group and four patients in the case group, of which the expression of 242 was upregulated and that of six was downregulated. The results of GO functional enrichment analysis mainly included behavior regulation, cell connection, and antioxidant activity. The results of KEGG pathway enrichment analysis mainly included ribosomes, proteasomes, oxytocin signaling pathways, and oxidative phosphorylation. After researching and screening based on relevant literature, it was found that among the genes with significant differential expression, H3F3B mRNA may be associated with and might play an important role in ACI. The qRT-PCR method was used to detect the H3F3B mRNA expression in serum exosomes of 32 patients each in the normal control and case groups in Phase Ⅱ; the expression was significantly higher in serum exosomes of the case group than in those of the normal control group (P < 0.001). H3F3B mRNA expression in serum exosomes of the case group positively correlated with age, the National Institutes of Health Stroke Scale (NIHSS) score, and the maximum infarct size (P < 0.05). Conclusion ACI can lead to changes in the serum exosomes mRNA expression profile, which may be closely related to the occurrence, development, and prognosis of this condition. These findings will provide direction for research on the molecular mechanism, diagnostic markers, and therapeutic targets of ACI.

Change of 4-1BB ligand expression of peripheral blood mononuclear cells in patients with atherosclerotic acute cerebral infarction

Analysis of correlation between oxidized low density lipoprotein and thrombus precursor protein with acute cerebral infarction

Study on the Changes of Serum Levels of Interleukin-1β(IL-1β) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Study on the Changes of Plasma Levels of Brain natriureticpeptide(BNP) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Expression of CD40 and CD40L on peripheral blood mononuclear cells in patients with acute coronary syndromes

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Change of serum soluble intercellular adhesion molecule and basic fibroblast growth factor in patients with acute cerebral infarction and its clinical significance]

Serum Concentrations of Adiponectin and Interlukin-10(IL-10) in Patients with Acute Cerebral Infarction

Changes of serum levels of interleukin-18 and tissue factor and its correlation with blood coagulation function in patients with acute cerebral infarction

Changes of Platelet Activation Markers and Platelet Ultra-Microstructure in the Patients with Acute Myocardial Infarction

The Research about the State of the Activated Blood Platelet of Cerebral Infarction Patients

Study on expression of platelet membrane glycoproteins in cerebral infarction with carotid atherosclerosis

Changes in plasma angiotensinogen concentration in atherosclerotic cerebral infarction and its implication

Dynamic Changes of Th1/Th2 Subsets in Patients with Acute Coronary Syndrome

Changes of the Plasma Level of High Sensitive C-reactive Protein, Nitric Oxide and Nitric Oxide Synthase in Patients with Acute Cerebral Infarction and Their Correlations

Study on differential gene expression profile of serum exosomes in patients with acute cerebral infarction

Increased Soluble CD137 Levels and CD4+ T‐Cell‐Associated Expression of CD137 in Acute Atherothrombotic Stroke

Expression pattern of the bone morphogenetic protein-4 and its relationship with inflammation, vascular injury in patients suffered the arterial occlusive diseases

Evaluation of lipoprotein‐associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction

Disregulated expression of co-stimulatory molecules PD-1 and CD28 on peripheral T lymphocytes in patients with acute coronary syndrome